Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Johnson & Johnson (NY: JNJ )

154.35 -0.06 (-0.04%)
Official Closing Price Updated: 7:00 PM EDT, May 26, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Johnson & Johnson

< Previous 1 2 3 4 5 6 7 8 9
...
68 69 Next >
7 Undervalued Blue-Chip Stocks to Buy for June 2023
These top undervalued blue-chip stocks offer a significant amount of upside as we get into the second half of 2023. 
Via InvestorPlace
Buy the Dip On These Warren Buffett Stocks
You'll want to follow Buffett's lead and hold on to these stocks forever. 
Via The Motley Fool
3 Dow Stocks Poised for a Roaring Relief Rally
Here are some compelling Dow stocks to buy if you believe the market may be on the cusp of a relief rally this summer. 
Via InvestorPlace
Smokeless Tobacco Treatment Market to See Booming Growth : Novartis, Pfizer, Johnson & Johnson, Cambrex
Smokeless Tobacco Treatment Comprehensive Study by Type (Keratosis Treatment, Addiction Treatment, Disease Treatment), Application (Hospitals & Clinics, Academic & Research Organizations, Pharmacies),... 
Via SBWire
Exposures Climate
Check Out What Whales Are Doing With JNJ
 
Via Benzinga
Better Buy: Medtronic vs. Johnson & Johnson
Both companies are medical device leaders. 
Via The Motley Fool
Healthcare Week boon for medical industry
From HKTDC
Via ACN Newswire
Want Passive Income Forever? Buy These 2 Magnificent Stocks Now
You can take these companies' dividends straight to the bank. 
Via The Motley Fool
A Challenger to J&J's Top Blockbuster Is on the Way. Here's What You Need to Know.
Biotech-giant Amgen aims to launch a rival. 
Via The Motley Fool
Value Stocks Hit 15-Month Low Against Growth As AI Fuels Tech's Vengeance Over 2022's Rate-Hike-Induced Market Fall
Value stocks fell to a seven-month low in relation to growth stocks, already lagging by more than 20% year to date on the heels of an AI-related rally propelling equities in the technology sector.  
Via Benzinga
Wall Street's Most Accurate Analysts Say Buy These 3 Health Care Stocks With Over 3% Dividend Yields
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high... 
Via Benzinga
New Data Out Of Cleveland Clinic Shows BioSig PURE EP May Be Used For More Precise Approach For $6 Billion Annual Atrial Fibrillation Market
Cleveland Clinic researchers presented data from three new studies involving BioSig Technologies’ (NASDAQ: BSGM) proprietary PURE EP Platform at the annual Heart Rhythm 2023 meeting in Ne 
Via Benzinga
Ranked: Who Made The Most U.S. Unicorn Acquisitions Since 1997?
Unicorn acquisitions are driven by two factors: the rate at which new unicorns are minted, and the climate for M&A transactions more broadly. 
Via Talk Markets
7 Safe-Haven Stocks to Buy for Protection From a U.S. Debt Default Disaster
With so many uncertainties about federal financial obligations, investors should target these safe-haven stocks for debt default. 
Via InvestorPlace
Buying These 2 Stocks Is a Good Way to Hedge Against a Market Crash
Both companies have produced consistent revenue growth and predictable profitability. 
Via The Motley Fool
Will Dividends Take Center Stage In The Second Half Of 2023?
The NYSE Composite's sideways trade since early 2021 could be a warning sign, suggesting that a shift toward dividend strategies may be prudent. 
Via MarketBeat
Topics Artificial Intelligence
Exposures Artificial Intelligence
Rain Oncology Shares Plummet: Company Discloses Disappointing Cancer Study Data After Delaying Readout
Rain Oncology Inc (NASDAQ: RAIN) announced topline Phase 3 MANTRA data of milademetan in patients with  
Via Benzinga
Immix Biopharma's Subsidiary Says Investigational CAR T Therapy Shows 100% Response Rate In Amyloidosis
Immix Biopharma Inc's (NASDAQ: IMMX) subsidiary Nexcella Inc announced updated AL Amyloidosis clinical data from its ongoing Phase 1b/2a NEXICART-1 study of its BCMA-targeted chimeric antigen receptor... 
Via Benzinga
Got $1,000? 5 Buffett Stocks to Buy and Hold Forever
Warren Buffett owns many stocks, but these five have solid growth potential. 
Via The Motley Fool
3 Relatively Safe Stocks to Buy if a Recession Is on the Way
If the economy falters, these stocks should hold up better than most. 
Via The Motley Fool
WHO Recommends New COVID Booster Shots To Target XBB Variants, Despite Slower Uptake
An advisory group for the World Health Organization said the current crop of shots should be updated to target the currently dominant XBB strains for the 
Via Benzinga
FDA Approves First Oral Treatment For Crohn's Disease, Making Seventh Approval For AbbVie's Rinvoq
The FDA approved AbbVie Inc's (NASDAQ: ABBV) Rinvoq (upadacitinib) for moderately to severely active Crohn's disease patients with inadequate response or intolerance to  
Via Benzinga
Kenvue Just IPO'd, but Is the Stock a Buy?
The Johnson & Johnson spinoff is worth considering, but it's not a must-buy. 
Via The Motley Fool
Tesla, Apple, Microsoft Stakes Slashed By New York State Retirement Fund In Q1: Here's What It Bought
 
Via Benzinga
Tampons Market Is Booming Worldwide : Johnson & Johnson, Kimberly-Clark, Ontex, Unicharm
Tampons Comprehensive Study by Type (Radially Wound Pledget, Rectangular/Square Pad), Distribution Channel (Online, Offline (Supermarkets/Hypermarkets, Independent Retailers, Specialty Stores, Drug... 
Via SBWire
Exposures Textiles
Artificial Intelligence Engine Predicts NVAX Stock to Gain 7% by June 15
Watch our new video to find out how you can get 3,000 more predictions just like this 
Via InvestorPlace
7 High-Quality Dow Stocks to Buy on the Dip
These seven Dow stocks each trade at attractive valuations, and have the potential to produce steady long-term returns. 
Via InvestorPlace
3 Reliable Dividend Stocks That Fit in Any Investor’s Portfolio
There are some reliable dividend stocks that everyone can and should consider owning. Here are three of them that fit the bill. 
Via InvestorPlace
Apple Thwarts $2B In Fraud Transactions, UBS Takes $17B Hit From 'Hasty Credit Suisse Takeover,' Verizon Streamlines Unlimited Data Plans: Today's Top Stories
Benzinga 
Via Benzinga
2 Dividend Stocks to Double Up On Right Now
These dividend stocks look attractive right now. 
Via The Motley Fool
< Previous 1 2 3 4 5 6 7 8 9
...
68 69 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.